Table 3.

Odds ratio for In-hospital mortality according to heart rate fluctuation.

Group	No. of group	No. of mortality	Model 1			Model 2			Model 3			Model 4
			Odds ratio	p-value	p for trend	Odds ratio	p-value	p for trend	Odds ratio	p-value	p for trend	Odds ratio	p-value	p for trend
Quantile 1	2695	471	reference		< 0.001	reference		< 0.001	reference		0.003	reference		0.002
Quantile 2	2695	494	1.067 (0.928–1.227)	0.366		1.044 (0.906–1.202)	0.554		1.047 (0.904–1.212)	0.541		1.056 (0.912–1.224)	0.466
Quantile 3	2695	545	1.223 (1.066–1.403)	0.004		1.173 (1.02–1.35)	0.025		1.165 (1.007–1.347)	0.040		1.190 (1.028–1.378)	0.020
Quantile 4	2695	577	1.32 (1.152–1.513)	< 0.001		1.225 (1.065–1.411)	0.005		1.151 (0.994–1.333)	0.060		1.174 (1.012–1.362)	0.034
Quantile 5	2695	620	1.482 (1.295–1.698)	< 0.001		1.293 (1.121–1.493)	< 0.001		1.230 (1.059–1.429)	0.007		1.254 (1.074–1.463)	0.004

a: adjusted for age, sex, new onset atrial fibrillation.

b: adjusted for age, sex, new onset atrial fibrillation, heart rate, systolic blood pressure, diastolic blood pressure, respiratory rate, saturation of percutaneous oxygen.

c: adjusted for age, sex, new onset atrial fibrillation, heart rate, systolic blood pressure, diastolic blood pressure, respiratory rate, saturation of percutaneous oxygen, congestive heart failure, hypertension, diabetes, chronic kidney disease, chronic liver disease, metastatic cancer, intubation, continuous kidney replacement therapy, blood culture positive, heart surgery, aorta surgery, glasgow coma scale.

d: adjusted for age, sex, new onset atrial fibrillation, heart rate, systolic blood pressure, diastolic blood pressure, respiratory rate, saturation of percutaneous oxygen, congestive heart failure, hypertension, diabetes, chronic kidney disease, chronic liver disease, metastatic cancer, intubation, continuous kidney replacement therapy, blood culture positive, heart surgery, aorta surgery, glasgow coma scale, norepinephrine, dopamine, dobutamine, epinephrine, vasopressin, rhythm control, rate control.